Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures

Clinical trial NCT00060996 · TERMINATED

Trial details

NCT number: NCT00060996
Sponsor: United Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Critical Limb Ischemia Peripheral Vascular Disease Foot Ulcers Rest Leg Pain

Start date: 2003-02-01
Primary completion: 2004-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.